Dermatology Times

OCTOBER 30, 2024

Bob Rhatigan, CEO of Merz Aesthetics, discusses the company’s commitment to advancing the aesthetics industry through strategic partnerships, specialized training, and a growing portfolio of injectables and devices.

Innovations 74

Innovations Portfolios Education Medical 74

AAAMS

JANUARY 4, 2023

Aesthetics is a growing, profitable and rewarding part of the medical field. As the industry grows, many medical practices that adopt aesthetic procedures will thrive. How to Open a Brand New Practice as a Medical Aesthetician Starting a medical aesthetics practice can be a new and unfamiliar process.

Networking 52

Networking Entrepreneurship Social Media Partnerships 52

The Dermatology Digest

SEPTEMBER 9, 2024

Obagi Introduces Two New Elastiderm Products Obagi Medical is launching Elastiderm Lift Up & Sculpt Facial Moisturizer and Elastiderm Advanced Filler Concentrate.

Portfolios 36

Portfolios Dermatology Injections Marketing 36

Spa Executive

JANUARY 16, 2024

The role of Vice President of Wellbeing is new for the brand, but an essential step in Jumeirah Group’s journey as they continue to invest in advancing the wellbeing offering through new concepts, therapies, and partnerships, which are all designed to enrich the wellness experience of guests.

Hospital 52

Hospital Technology Branding Portfolios 52

Spa Executive

JUNE 19, 2024

Managing an extensive portfolio of more than 120 hotels, including 26 major brands and 19 boutique properties, Remington has positioned itself as a leader in the hospitality industry. I love the partnerships with beverage and food that include so many nourishing options. I am also excited about new openings and partnerships.

Hospital 52

Hospital Technology Sustainability Management 52

Aesthetics Advisor

SEPTEMBER 15, 2023

However, medications that are already authorized are just a small percentage of what's been studied. Many researchers are still trying to find and develop other medications that can treat or prevent COVID-19. The product is authorized as a medical device targeting COVID-19 in India, Israel, Bahrain, Indonesia and Thailand.

Hospital 69

Hospital Clinic Marketing Medical 69

The Dermatology Digest

DECEMBER 21, 2023

The two distribution agreements for the Evolysse /Estyme fillers portfolio will grant Evolus the ability to offer filler solutions to cover mid-face, nasolabial folds, and lip indications in Europe plus an eye product line in the U.S. We are extremely excited to expand our partnership with Evolus beyond the U.S. to now include the U.K.

Marketing 36

Marketing Sales Branding Portfolios 36